{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:56:27Z","timestamp":1781571387730,"version":"3.54.5"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Pulmonology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The seasonality of respiratory syncytial virus (RSV) epidemics have been disrupted during the COVID\u201019 pandemic, possibly because of lockdowns and social restrictions reducing viral transmission. Given uncertainties around the severity of upcoming RSV bronchiolitis epidemics, debate exists whether palivizumab (RSV prophylaxis) should be administered to infants with Congenital Diaphragmatic Hernia (CDH), who may be vulnerable due to lung hypoplasia and pulmonary hypertension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate (1) if CDH infants have higher risk of admission with RSV bronchiolitis than infants in the general population; (2) if palivizumab prophylaxis may reduce this risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included all eligible studies examining the risk(s) of RSV\u2010positive bronchiolitis requiring hospital admission in (1) CDH infants without palivizumab prophylaxis versus infants in the general population and (2) CDH infants with prophylaxis versus CDH infants without prophylaxis. The primary outcome evaluated was the risk of admission with RSV bronchiolitis. Data are reported descriptively and meta\u2010analysed when appropriate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Three eligible retrospective cohort studies were identified: one study found CDH to be an independent risk factor for RSV hospitalisation (odds ratio, 3.30; 95% confidence interval [CI], 2.01\u20134.4); two studies compared RSV hospitalisation rates in CDH patients who had palivizumab versus those that did not. The pooled risk ratio was 1.11 (95% CI, 0.29\u20134.23; <jats:italic>p<\/jats:italic>\u2009=\u2009.88). Overall, the quality of evidence was considered poor and one study was industry funded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Whether CDH infants are at particular risk of severe bronchiolitis remains unclear. There is no evidence from this current systematic review that CDH infants should routinely receive palivizumab vaccination prophylaxis.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ppul.25717","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T19:30:15Z","timestamp":1633721415000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis"],"prefix":"10.1002","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-0363","authenticated-orcid":false,"given":"Leonie","family":"Lewis","sequence":"first","affiliation":[{"name":"Women's And Children's Health University of Liverpool  Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Sinha","sequence":"additional","affiliation":[{"name":"Alder Hey Children's Hospital NHS Foundation Trust  Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Losty","sequence":"additional","affiliation":[{"name":"Women's And Children's Health University of Liverpool  Liverpool UK"},{"name":"Alder Hey Children's Hospital NHS Foundation Trust  Liverpool UK"},{"name":"Faculty Of Health And Life Sciences University of Liverpool  Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"Bronchiolitis: National Health Service (NHS).2015. Accessed 08\/03\/2021.https:\/\/www.nhs.uk\/conditions\/bronchiolitis"},{"key":"e_1_2_9_3_1","unstructured":"Bronchiolitis: British Lung Foundation.2018. Accessed 08\/03\/21.https:\/\/www.blf.org.uk\/support-for-you\/bronchiolitis"},{"key":"e_1_2_9_4_1","unstructured":"Bronchiolitis: Great Ormond Street Hospital for Children NHS Foundation Trust; 2020 [updated March 2016. Accessed 08\/03\/2021.https:\/\/www.gosh.nhs.uk\/conditions-and-treatments\/conditions-we-treat\/bronchiolitis"},{"key":"e_1_2_9_5_1","volume-title":"Pediatric bronchiolitis","author":"Erickson EN","year":"2021"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-03968-6"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-320469"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30307-2"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","unstructured":"FoleyDA YeohDK Minney\u2010SmithCA et al. The interseasonal resurgence of respiratory syncytial virus in australian children following the reduction of coronavirus disease 2019\u2010related public health measures. Clin Infect Dis. Published online February 17 2021.doi:10.1093\/cid\/ciaa1906","DOI":"10.1093\/cid\/ciaa1906"},{"key":"e_1_2_9_10_1","unstructured":"Respiratory syncytial virus: National Institute for Health and Care Excellence.2021. Accessed 08\/03\/21https:\/\/bnf.nice.org.uk\/treatment-summary\/respiratory-syncytial-virus.html"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.4103\/1658-354X.152900"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0225"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002666"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.08.006"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.07.020413"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12431"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2014.09.008"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22826"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_2_9_20_1","unstructured":"HigginsJ ThomasJ ChandlerJ et al.Cochrane handbook for systematic reviews of interventions version 6.2.Cochrane.2021. (updated February 2021.www.training.cochrane.org\/handbook"},{"key":"e_1_2_9_21_1","unstructured":"CASP Cohort Study Checklist: Critical Appraisal Skills Programme. 2019. Accessed 10\/03\/2021.https:\/\/caspuk.net\/wp-content\/uploads\/2018\/01\/CASP-Cohort-Study-Checklist_2018.pdf"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-3782(12)70012-9"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.20031"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1654-8"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2004.09.037"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1010"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2020.03.003"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2008.02580.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229766"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2017.08.005"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155556"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2018.11.001"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403086"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2018.10.072"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.058081"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.25717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ppul.25717","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.25717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T12:52:39Z","timestamp":1692967959000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.25717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1002\/ppul.25717"],"URL":"https:\/\/doi.org\/10.1002\/ppul.25717","archive":["Portico"],"relation":{},"ISSN":["8755-6863","1099-0496"],"issn-type":[{"value":"8755-6863","type":"print"},{"value":"1099-0496","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"2021-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}